Literature DB >> 10202157

Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization.

M Blanchette1, B Chabot.   

Abstract

The RNA-binding protein hnRNP A1 is a splicing regulator produced by exclusion of alternative exon 7B from the A1 pre-mRNA. Each intron flanking exon 7B contains a high-affinity A1-binding site. The A1-binding elements promote exon skipping in vivo, activate distal 5' splice site selection in vitro and improve the responsiveness of pre-mRNAs to increases in the concentration of A1. Whereas the glycine-rich C-terminal domain of A1 is not required for binding, it is essential to activate the distal 5' splice site. Because A1 complexes can interact simultaneously with two A1-binding sites, we propose that an interaction between bound A1 proteins facilitates the pairing of distant splice sites. Based on the distribution of putative A1-binding sites in various pre-mRNAs, an A1-mediated change in pre-mRNA conformation may help define the borders of mammalian introns. We also identify an intron element which represses the 3' splice site of exon 7B. The activity of this element is mediated by a factor distinct from A1. Our results suggest that exon 7B skipping results from the concerted action of several intron elements that modulate splice site recognition and pairing.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10202157      PMCID: PMC1171279          DOI: 10.1093/emboj/18.7.1939

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  73 in total

1.  Identification of two RNA-binding proteins in Balbiani ring premessenger ribonucleoprotein granules and presence of these proteins in specific subsets of heterogeneous nuclear ribonucleoprotein particles.

Authors:  E Kiseleva; G Nacheva; A Alzhanova-Ericcson; A Rosén; B Daneholt
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

2.  Soma-specific expression and cloning of PSI, a negative regulator of P element pre-mRNA splicing.

Authors:  C W Siebel; A Admon; D C Rio
Journal:  Genes Dev       Date:  1995-02-01       Impact factor: 11.361

3.  The A1 and A1B proteins of heterogeneous nuclear ribonucleoparticles modulate 5' splice site selection in vivo.

Authors:  X Yang; M R Bani; S J Lu; S Rowan; Y Ben-David; B Chabot
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

4.  Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors.

Authors:  J F Cáceres; S Stamm; D M Helfman; A R Krainer
Journal:  Science       Date:  1994-09-16       Impact factor: 47.728

5.  A novel bipartite splicing enhancer modulates the differential processing of the human fibronectin EDA exon.

Authors:  M Caputi; G Casari; S Guenzi; R Tagliabue; A Sidoli; C A Melo; F E Baralle
Journal:  Nucleic Acids Res       Date:  1994-03-25       Impact factor: 16.971

6.  SR proteins promote the first specific recognition of Pre-mRNA and are present together with the U1 small nuclear ribonucleoprotein particle in a general splicing enhancer complex.

Authors:  D Staknis; R Reed
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

7.  Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins.

Authors:  R Singh; J Valcárcel; M R Green
Journal:  Science       Date:  1995-05-26       Impact factor: 47.728

8.  Predicting internal exons by oligonucleotide composition and discriminant analysis of spliceable open reading frames.

Authors:  V V Solovyev; A A Salamov; C B Lawrence
Journal:  Nucleic Acids Res       Date:  1994-12-11       Impact factor: 16.971

9.  Synergistic interactions between two distinct elements of a regulated splicing enhancer.

Authors:  K W Lynch; T Maniatis
Journal:  Genes Dev       Date:  1995-02-01       Impact factor: 11.361

10.  Function of conserved domains of hnRNP A1 and other hnRNP A/B proteins.

Authors:  A Mayeda; S H Munroe; J F Cáceres; A R Krainer
Journal:  EMBO J       Date:  1994-11-15       Impact factor: 11.598

View more
  83 in total

1.  Polypyrimidine track-binding protein binding downstream of caspase-2 alternative exon 9 represses its inclusion.

Authors:  J Côté; S Dupuis; J Y Wu
Journal:  J Biol Chem       Date:  2000-12-14       Impact factor: 5.157

2.  Evaluation of the role of heterogeneous nuclear ribonucleoprotein A1 as a host factor in murine coronavirus discontinuous transcription and genome replication.

Authors:  X Shen; P S Masters
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

3.  An intronic splicing enhancer binds U1 snRNPs to enhance splicing and select 5' splice sites.

Authors:  A J McCullough; S M Berget
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

4.  Multiple splicing defects in an intronic false exon.

Authors:  H Sun; L A Chasin
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

Review 5.  RNA-protein interactions that regulate pre-mRNA splicing.

Authors:  Ravinder Singh
Journal:  Gene Expr       Date:  2002

6.  The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.

Authors:  T O Tange; C K Damgaard; S Guth; J Valcárcel; J Kjems
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

7.  SRp30c is a repressor of 3' splice site utilization.

Authors:  Martin J Simard; Benoit Chabot
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

8.  Control of hnRNP A1 alternative splicing: an intron element represses use of the common 3' splice site.

Authors:  M J Simard; B Chabot
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

Review 9.  Polypyrimidine tract binding protein antagonizes exon definition.

Authors:  E J Wagner; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

10.  Roles of hnRNP A1, SR proteins, and p68 helicase in c-H-ras alternative splicing regulation.

Authors:  Sònia Guil; Renata Gattoni; Montserrat Carrascal; Joaquín Abián; James Stévenin; Montse Bach-Elias
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.